Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Intestinal ultrasound in inflammatory bowel disease

Asthana AK

(2016), J Gastroenterol Hepatol, 31 Suppl 1,

WFUMB position paper. Learning gastrointestinal ultrasound: theory and practice

Atkinson NS, Bryant RV, Dong Y, Maaser C, Kucharzik T, Maconi G, Asthana AK, Blaivas M, Goudie A, Gilja OH, NolsØe C, Nürnberg D, Dietrich CF

(2016), Ultrasound Med Biol, 42(12),

Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis

Taylor KM, Sparrow MP

(2016), Aliment Pharmacol Ther, 43(9),

Appropriateness of testing for anti-tumor necrosis factor agent and antibody concentrations, and interpretation of results

Melmed GY, Irving PM, Jones J, Kaplan GG, Kozuch PL, Velayos FS, Baidoo L, Sparrow MP, Bressler B, Cheifetz AS, Devlin SM, Raffals LE, Vande Casteele N, Mould DR, Colombel JF, Dubinsky M, Sandborn WJ, Siegel CA

(2016), Clin Gastroenterol Hepatol, 14(9),

A retrospective comparison of infliximab versus adalimumab as induction and maintenance therapy for Crohn disease

Varma P, Paul E, Huang C, Headon B, Sparrow MP

(2016), Intern Med J, 46(7),

Recommendations for quality colonoscopy reporting for patients with inflammatory bowel disease: results from a RAND appropriateness panel

Devlin SM, Melmed GY, Irving PM, Rubin DT, Kornbluth A, Kozuch PL, Raffals LE, Velayos FS, Sparrow MP, Baidoo L, Bressler B, Cheifetz AS, Jones J, Kaplan GG, Siegel CA

(2016), Inflamm Bowel Dis, 22(6),

Thiopurines best practice

Friedman A

(2016), J Gastroenterol Hepatol, 31 Suppl 1,

Letter: dietary therapy in eosinophilic oesophagitis - do not test, just eliminate and reintroduce the most common food triggers. Authors' reply

Philpott H, Gibson PR

(2016), Aliment Pharmacol Ther, 44(8),

The White Diet is preferred, better tolerated, and non-inferior to a clear-fluid diet for bowel preparation: a randomized controlled trial

Butt J, Bunn C, Paul E, Gibson P, Brown G

(2016), J Gastroenterol Hepatol, 31(2),

Research topic: managing compassionate therapy-the role of the virtual clinic

Ward M

(2016), J Gastroenterol Hepatol, 31 Suppl 1,

Supersonic shear imaging and transient elastrography in obesity

Thwaites PA, Roberts SK, Kitson M, Kemp W

(2016), Clin Gastroenterol Hepatol, 14(3),

Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study

Doyle A, Marsh P, Gill R, Rodov M, Mohsen W, Varma P, Hong T, Strasser SI, Bell S, Ryan M, Nicoll A, Lubel J, Gow PJ, Fink MA, Roberts S, Kemp W, Kronborg I, Arachchi N, Knight V, Dev A

(2016), Scand J Gastroenterol, 51(8),

Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease

Ngu PJ, Butler M, Pham A, Roberts SK, Taylor AJ

(2016), Int J Cardiovasc Imaging, 32(4),

Direct-acting antiviral therapies for hepatitis C: the revolution is here

Kitson MT, Roberts SK

(2016), Med Today, 17(3),

Systemic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis

Majumdar A, Kitson MT, Roberts SK

(2016), Aliment Pharmacol Ther, 43(12),

Ribavirin-free regimen with sofosbuvir and velpatasvir is associated with high efficacy and improvement of patient-reported outcomes in patients with genotypes 2 and 3 chronic hepatitis C: results from Astral-2 and 3 clinical trials

Younossi ZM, Stepanova M, Sulkowski M, Foster GR, Reau N, Mangia A, Patel K, Bräu N, Roberts SK, Afdhal N, Nader F, Henry L, Hunt S

(2016), Clin Infect Dis, 63(8),

Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed

Hong TP, Gow P, Fink M, Dev A, Roberts S, Nicoll A, Lubel J, Kronborg I, Arachchi N, Ryan M, Kemp W, Knight V, Farrugia H, Thursfield V, Desmond P, Thompson AJ, Bell S

(2016), Hepatology, 63(4),

Liver stiffness plus platelet count can be used to exclude high-risk oesophageal varices

Ding NS, Nguyen T, Iser DM, Hong T, Flanagan E, Wong A, Luiz L, Tan JY, Fulforth J, Holmes J, Ryan M, Bell SJ, Desmond PV, Roberts SK, Lubel J, Kemp W, Thompson AJ

(2016), Liver Int, 36(2),

Is early rehabilitation a myth? Physical inactivity in the first week after myocardial infarction and stroke

Lay S, Bernhardt J, West T, Churilov L, Dart A, Hayes K, Cumming TB

(2016), Disabil Rehabil, 38(15),

Anti-fibrinolytics

Draxler DF, Medcalf RL, Gruen RL

(2016), In: Gonzalez E, Moore HB, Moore EE (eds), Trauma Induced Coagulopathy, Springer International Publishing,

273 274 275 276 277